About Us Services Careers FAQ Contact Us 0
Home Healthcare IT Intravenous to Subcutaneous Drug Repositioning Market Size, Growth, 2031
Intravenous to Subcutaneous Drug Repositioning Market
Intravenous to Subcutaneous Drug Repositioning Market

Intravenous to Subcutaneous Drug Repositioning Market Size, Share & Trends Analysis Report By Product (Devices, Drugs), By Therapeutic (Cardiology, Oncology, Pulmonary arterial hypertension, Hematology, Others), By End-user (Hospitals and clinics, Research facilities, Others) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2024-2032

Report Code: SRHI681DR
Last Updated : Jun 20, 2023
Author : Straits Research
Starting From
USD 1850
Buy Now
File Formats

Market Segmentation

  1. Intravenous to Subcutaneous Drug Repositioning Market, By Product (2021-2031)
    1. Devices
      1. Wearable SC injectors
      2. Wearable SC infusers
    2. Drugs
      1. Cancer drugs
      2. Blood factors
      3. Immunoglobulin G
      4. Antibiotics
      5. Remodulin
      6. Others
  2. Intravenous to Subcutaneous Drug Repositioning Market, By Therapeutic (2021-2031)
    1. Cardiology
    2. Oncology
    3. Pulmonary arterial hypertension
    4. Hematology
    5. Others
  3. Intravenous to Subcutaneous Drug Repositioning Market, By End-user (2021-2031)
    1. Hospitals and clinics
    2. Research facilities
    3. Others
    1. North America
      1. North America Intravenous to Subcutaneous Drug Repositioning Market, By Product
        1. Devices
          1. Wearable SC injectors
            1. Wearable SC infusers
            2. Drugs
              1. Cancer drugs
                1. Blood factors
                  1. Immunoglobulin G
                    1. Antibiotics
                      1. Remodulin
                        1. Others
                      2. North America Intravenous to Subcutaneous Drug Repositioning Market, By Therapeutic
                        1. Cardiology
                          1. Oncology
                            1. Pulmonary arterial hypertension
                              1. Hematology
                                1. Others
                                2. North America Intravenous to Subcutaneous Drug Repositioning Market, By End-user
                                  1. Hospitals and clinics
                                    1. Research facilities
                                      1. Others
                                      2. U.S.
                                        1. U.S. Intravenous to Subcutaneous Drug Repositioning Market, By Product
                                          1. Devices
                                            1. Wearable SC injectors
                                              1. Wearable SC infusers
                                              2. Drugs
                                                1. Cancer drugs
                                                  1. Blood factors
                                                    1. Immunoglobulin G
                                                      1. Antibiotics
                                                        1. Remodulin
                                                          1. Others
                                                        2. U.S. Intravenous to Subcutaneous Drug Repositioning Market, By Therapeutic
                                                          1. Cardiology
                                                            1. Oncology
                                                              1. Pulmonary arterial hypertension
                                                                1. Hematology
                                                                  1. Others
                                                                  2. U.S. Intravenous to Subcutaneous Drug Repositioning Market, By End-user
                                                                    1. Hospitals and clinics
                                                                      1. Research facilities
                                                                        1. Others
                                                                      2. Canada
                                                                    2. Europe
                                                                      1. Europe Intravenous to Subcutaneous Drug Repositioning Market, By Product
                                                                        1. Devices
                                                                          1. Wearable SC injectors
                                                                            1. Wearable SC infusers
                                                                            2. Drugs
                                                                              1. Cancer drugs
                                                                                1. Blood factors
                                                                                  1. Immunoglobulin G
                                                                                    1. Antibiotics
                                                                                      1. Remodulin
                                                                                        1. Others
                                                                                      2. Europe Intravenous to Subcutaneous Drug Repositioning Market, By Therapeutic
                                                                                        1. Cardiology
                                                                                          1. Oncology
                                                                                            1. Pulmonary arterial hypertension
                                                                                              1. Hematology
                                                                                                1. Others
                                                                                                2. Europe Intravenous to Subcutaneous Drug Repositioning Market, By End-user
                                                                                                  1. Hospitals and clinics
                                                                                                    1. Research facilities
                                                                                                      1. Others
                                                                                                      2. U.K.
                                                                                                        1. U.K. Intravenous to Subcutaneous Drug Repositioning Market, By Product
                                                                                                          1. Devices
                                                                                                            1. Wearable SC injectors
                                                                                                              1. Wearable SC infusers
                                                                                                              2. Drugs
                                                                                                                1. Cancer drugs
                                                                                                                  1. Blood factors
                                                                                                                    1. Immunoglobulin G
                                                                                                                      1. Antibiotics
                                                                                                                        1. Remodulin
                                                                                                                          1. Others
                                                                                                                        2. U.K. Intravenous to Subcutaneous Drug Repositioning Market, By Therapeutic
                                                                                                                          1. Cardiology
                                                                                                                            1. Oncology
                                                                                                                              1. Pulmonary arterial hypertension
                                                                                                                                1. Hematology
                                                                                                                                  1. Others
                                                                                                                                  2. U.K. Intravenous to Subcutaneous Drug Repositioning Market, By End-user
                                                                                                                                    1. Hospitals and clinics
                                                                                                                                      1. Research facilities
                                                                                                                                        1. Others
                                                                                                                                      2. Germany
                                                                                                                                      3. France
                                                                                                                                      4. Spain
                                                                                                                                      5. Italy
                                                                                                                                      6. Russia
                                                                                                                                      7. Nordic
                                                                                                                                      8. Benelux
                                                                                                                                      9. Rest of Europe
                                                                                                                                    2. APAC
                                                                                                                                      1. APAC Intravenous to Subcutaneous Drug Repositioning Market, By Product
                                                                                                                                        1. Devices
                                                                                                                                          1. Wearable SC injectors
                                                                                                                                            1. Wearable SC infusers
                                                                                                                                            2. Drugs
                                                                                                                                              1. Cancer drugs
                                                                                                                                                1. Blood factors
                                                                                                                                                  1. Immunoglobulin G
                                                                                                                                                    1. Antibiotics
                                                                                                                                                      1. Remodulin
                                                                                                                                                        1. Others
                                                                                                                                                      2. APAC Intravenous to Subcutaneous Drug Repositioning Market, By Therapeutic
                                                                                                                                                        1. Cardiology
                                                                                                                                                          1. Oncology
                                                                                                                                                            1. Pulmonary arterial hypertension
                                                                                                                                                              1. Hematology
                                                                                                                                                                1. Others
                                                                                                                                                                2. APAC Intravenous to Subcutaneous Drug Repositioning Market, By End-user
                                                                                                                                                                  1. Hospitals and clinics
                                                                                                                                                                    1. Research facilities
                                                                                                                                                                      1. Others
                                                                                                                                                                      2. China
                                                                                                                                                                        1. China Intravenous to Subcutaneous Drug Repositioning Market, By Product
                                                                                                                                                                          1. Devices
                                                                                                                                                                            1. Wearable SC injectors
                                                                                                                                                                              1. Wearable SC infusers
                                                                                                                                                                              2. Drugs
                                                                                                                                                                                1. Cancer drugs
                                                                                                                                                                                  1. Blood factors
                                                                                                                                                                                    1. Immunoglobulin G
                                                                                                                                                                                      1. Antibiotics
                                                                                                                                                                                        1. Remodulin
                                                                                                                                                                                          1. Others
                                                                                                                                                                                        2. China Intravenous to Subcutaneous Drug Repositioning Market, By Therapeutic
                                                                                                                                                                                          1. Cardiology
                                                                                                                                                                                            1. Oncology
                                                                                                                                                                                              1. Pulmonary arterial hypertension
                                                                                                                                                                                                1. Hematology
                                                                                                                                                                                                  1. Others
                                                                                                                                                                                                  2. China Intravenous to Subcutaneous Drug Repositioning Market, By End-user
                                                                                                                                                                                                    1. Hospitals and clinics
                                                                                                                                                                                                      1. Research facilities
                                                                                                                                                                                                        1. Others
                                                                                                                                                                                                      2. Korea
                                                                                                                                                                                                      3. Japan
                                                                                                                                                                                                      4. India
                                                                                                                                                                                                      5. Australia
                                                                                                                                                                                                      6. Taiwan
                                                                                                                                                                                                      7. South East Asia
                                                                                                                                                                                                      8. Rest of Asia-Pacific
                                                                                                                                                                                                    2. Middle East and Africa
                                                                                                                                                                                                      1. Middle East and Africa Intravenous to Subcutaneous Drug Repositioning Market, By Product
                                                                                                                                                                                                        1. Devices
                                                                                                                                                                                                          1. Wearable SC injectors
                                                                                                                                                                                                            1. Wearable SC infusers
                                                                                                                                                                                                            2. Drugs
                                                                                                                                                                                                              1. Cancer drugs
                                                                                                                                                                                                                1. Blood factors
                                                                                                                                                                                                                  1. Immunoglobulin G
                                                                                                                                                                                                                    1. Antibiotics
                                                                                                                                                                                                                      1. Remodulin
                                                                                                                                                                                                                        1. Others
                                                                                                                                                                                                                      2. Middle East and Africa Intravenous to Subcutaneous Drug Repositioning Market, By Therapeutic
                                                                                                                                                                                                                        1. Cardiology
                                                                                                                                                                                                                          1. Oncology
                                                                                                                                                                                                                            1. Pulmonary arterial hypertension
                                                                                                                                                                                                                              1. Hematology
                                                                                                                                                                                                                                1. Others
                                                                                                                                                                                                                                2. Middle East and Africa Intravenous to Subcutaneous Drug Repositioning Market, By End-user
                                                                                                                                                                                                                                  1. Hospitals and clinics
                                                                                                                                                                                                                                    1. Research facilities
                                                                                                                                                                                                                                      1. Others
                                                                                                                                                                                                                                      2. UAE
                                                                                                                                                                                                                                        1. UAE Intravenous to Subcutaneous Drug Repositioning Market, By Product
                                                                                                                                                                                                                                          1. Devices
                                                                                                                                                                                                                                            1. Wearable SC injectors
                                                                                                                                                                                                                                              1. Wearable SC infusers
                                                                                                                                                                                                                                              2. Drugs
                                                                                                                                                                                                                                                1. Cancer drugs
                                                                                                                                                                                                                                                  1. Blood factors
                                                                                                                                                                                                                                                    1. Immunoglobulin G
                                                                                                                                                                                                                                                      1. Antibiotics
                                                                                                                                                                                                                                                        1. Remodulin
                                                                                                                                                                                                                                                          1. Others
                                                                                                                                                                                                                                                        2. UAE Intravenous to Subcutaneous Drug Repositioning Market, By Therapeutic
                                                                                                                                                                                                                                                          1. Cardiology
                                                                                                                                                                                                                                                            1. Oncology
                                                                                                                                                                                                                                                              1. Pulmonary arterial hypertension
                                                                                                                                                                                                                                                                1. Hematology
                                                                                                                                                                                                                                                                  1. Others
                                                                                                                                                                                                                                                                  2. UAE Intravenous to Subcutaneous Drug Repositioning Market, By End-user
                                                                                                                                                                                                                                                                    1. Hospitals and clinics
                                                                                                                                                                                                                                                                      1. Research facilities
                                                                                                                                                                                                                                                                        1. Others
                                                                                                                                                                                                                                                                      2. Turkey
                                                                                                                                                                                                                                                                      3. Saudi Arabia
                                                                                                                                                                                                                                                                      4. South Africa
                                                                                                                                                                                                                                                                      5. Egypt
                                                                                                                                                                                                                                                                      6. Nigeria
                                                                                                                                                                                                                                                                      7. Rest of MEA
                                                                                                                                                                                                                                                                    2. LATAM
                                                                                                                                                                                                                                                                      1. LATAM Intravenous to Subcutaneous Drug Repositioning Market, By Product
                                                                                                                                                                                                                                                                        1. Devices
                                                                                                                                                                                                                                                                          1. Wearable SC injectors
                                                                                                                                                                                                                                                                            1. Wearable SC infusers
                                                                                                                                                                                                                                                                            2. Drugs
                                                                                                                                                                                                                                                                              1. Cancer drugs
                                                                                                                                                                                                                                                                                1. Blood factors
                                                                                                                                                                                                                                                                                  1. Immunoglobulin G
                                                                                                                                                                                                                                                                                    1. Antibiotics
                                                                                                                                                                                                                                                                                      1. Remodulin
                                                                                                                                                                                                                                                                                        1. Others
                                                                                                                                                                                                                                                                                      2. LATAM Intravenous to Subcutaneous Drug Repositioning Market, By Therapeutic
                                                                                                                                                                                                                                                                                        1. Cardiology
                                                                                                                                                                                                                                                                                          1. Oncology
                                                                                                                                                                                                                                                                                            1. Pulmonary arterial hypertension
                                                                                                                                                                                                                                                                                              1. Hematology
                                                                                                                                                                                                                                                                                                1. Others
                                                                                                                                                                                                                                                                                                2. LATAM Intravenous to Subcutaneous Drug Repositioning Market, By End-user
                                                                                                                                                                                                                                                                                                  1. Hospitals and clinics
                                                                                                                                                                                                                                                                                                    1. Research facilities
                                                                                                                                                                                                                                                                                                      1. Others
                                                                                                                                                                                                                                                                                                      2. Brazil
                                                                                                                                                                                                                                                                                                        1. Brazil Intravenous to Subcutaneous Drug Repositioning Market, By Product
                                                                                                                                                                                                                                                                                                          1. Devices
                                                                                                                                                                                                                                                                                                            1. Wearable SC injectors
                                                                                                                                                                                                                                                                                                              1. Wearable SC infusers
                                                                                                                                                                                                                                                                                                              2. Drugs
                                                                                                                                                                                                                                                                                                                1. Cancer drugs
                                                                                                                                                                                                                                                                                                                  1. Blood factors
                                                                                                                                                                                                                                                                                                                    1. Immunoglobulin G
                                                                                                                                                                                                                                                                                                                      1. Antibiotics
                                                                                                                                                                                                                                                                                                                        1. Remodulin
                                                                                                                                                                                                                                                                                                                          1. Others
                                                                                                                                                                                                                                                                                                                        2. Brazil Intravenous to Subcutaneous Drug Repositioning Market, By Therapeutic
                                                                                                                                                                                                                                                                                                                          1. Cardiology
                                                                                                                                                                                                                                                                                                                            1. Oncology
                                                                                                                                                                                                                                                                                                                              1. Pulmonary arterial hypertension
                                                                                                                                                                                                                                                                                                                                1. Hematology
                                                                                                                                                                                                                                                                                                                                  1. Others
                                                                                                                                                                                                                                                                                                                                  2. Brazil Intravenous to Subcutaneous Drug Repositioning Market, By End-user
                                                                                                                                                                                                                                                                                                                                    1. Hospitals and clinics
                                                                                                                                                                                                                                                                                                                                      1. Research facilities
                                                                                                                                                                                                                                                                                                                                        1. Others
                                                                                                                                                                                                                                                                                                                                      2. Mexico
                                                                                                                                                                                                                                                                                                                                      3. Argentina
                                                                                                                                                                                                                                                                                                                                      4. Chile
                                                                                                                                                                                                                                                                                                                                      5. Colombia
                                                                                                                                                                                                                                                                                                                                      6. Rest of LATAM

                                                                                                                                                                                                                                                                                                                                  Related Reports

                                                                                                                                                                                                                                                                                                                                  Global Report
                                                                                                                                                                                                                                                                                                                                  The global bispecific antibodies market size was valued at USD 8.2 billion in 2023 and is projected to reach a value of USD 224.6 billion by 2032, registering a CAGR of 44.4% during the forecast period (2024-2032). The rise in cancer incidence is a c
                                                                                                                                                                                                                                                                                                                                  Buy Now
                                                                                                                                                                                                                                                                                                                                  Global Report
                                                                                                                                                                                                                                                                                                                                  The global X-Ray Inspection System Market size was valued at USD 734.5 Million in 2022 and is projected to reach USD 1231.3 Million by 2031, registering a CAGR of 6.6% during the forecast period (2023-2031). The rising awareness of the bene
                                                                                                                                                                                                                                                                                                                                  Buy Now
                                                                                                                                                                                                                                                                                                                                  Global Report
                                                                                                                                                                                                                                                                                                                                  Inflight Catering Market Size and Trends The global inflight catering market size was valued at USD 13.62 billion in 2023. It is projected to reach from USD 15.16 billion in 2024 to USD 35.75 billion by 2032, growing at a CAGR of 11.32% during the f
                                                                                                                                                                                                                                                                                                                                  Buy Now
                                                                                                                                                                                                                                                                                                                                  Global Report
                                                                                                                                                                                                                                                                                                                                  The global bladder scanners market size was valued at USD 141.70 million in 2022. It is projected to reach USD 232.38 million by 2031, growing at a CAGR of 5.65% during the forecast period (2023-2031). This is because many people globally have u
                                                                                                                                                                                                                                                                                                                                  Buy Now
                                                                                                                                                                                                                                                                                                                                  Global Report
                                                                                                                                                                                                                                                                                                                                  The global hair removal wax market size was valued at USD 13,110 million in 2022. It is estimated to reach USD 20,228 million by 2031, growing at a CAGR of 4.9% during the forecast period (2023–2031). Highlights Soft wax
                                                                                                                                                                                                                                                                                                                                  Buy Now

                                                                                                                                                                                                                                                                                                                                  Purchase Benefits

                                                                                                                                                                                                                                                                                                                                  • Eligible for a free updated report next year
                                                                                                                                                                                                                                                                                                                                  • Completely customizable scope
                                                                                                                                                                                                                                                                                                                                  • 30% discount on your next purchase
                                                                                                                                                                                                                                                                                                                                  • Dedicated account manager
                                                                                                                                                                                                                                                                                                                                  • Query resolution within 24 hours
                                                                                                                                                                                                                                                                                                                                  • Permission to print the report

                                                                                                                                                                                                                                                                                                                                  We are featured on :

                                                                                                                                                                                                                                                                                                                                  www.straitsresearch.com
                                                                                                                                                                                                                                                                                                                                  © Copyright . All rights Reserved.